The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Hospital Acquired Infection Treatment Market Research Report 2025

Global Hospital Acquired Infection Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1892789

No of Pages : 94

Ask Your Query
Synopsis
Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility.
The global Hospital Acquired Infection Treatment market was valued at US$ 18850 million in 2023 and is anticipated to reach US$ 21770 million by 2030, witnessing a CAGR of 1.6% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hospital Acquired Infection Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Acquired Infection Treatment.
Report Scope
The Hospital Acquired Infection Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hospital Acquired Infection Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital Acquired Infection Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Pfizer
Bayer
Cepheid
AstraZeneca
Roche
Johnson & Johnson
Merck
Cipla
GlaxoSmithKline
Aridis Pharmaceuticals
Astellas Pharma
Daiichi Sankyo
Bristol-Myers Squibb
Eli Lilly
Segment by Type
Urinary Tract Infections
Ventilator Associated Pneumonia
Surgical Site Infections
Bloodstream Infections
Gastrointestinal Infection
ENT Infections
Skin Infection
Bone Infection
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Store
E-Commerce
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital Acquired Infection Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital Acquired Infection Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Urinary Tract Infections
1.2.3 Ventilator Associated Pneumonia
1.2.4 Surgical Site Infections
1.2.5 Bloodstream Infections
1.2.6 Gastrointestinal Infection
1.2.7 ENT Infections
1.2.8 Skin Infection
1.2.9 Bone Infection
1.3 Market by Application
1.3.1 Global Hospital Acquired Infection Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Store
1.3.5 E-Commerce
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hospital Acquired Infection Treatment Market Perspective (2019-2030)
2.2 Hospital Acquired Infection Treatment Growth Trends by Region
2.2.1 Global Hospital Acquired Infection Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hospital Acquired Infection Treatment Historic Market Size by Region (2019-2024)
2.2.3 Hospital Acquired Infection Treatment Forecasted Market Size by Region (2025-2030)
2.3 Hospital Acquired Infection Treatment Market Dynamics
2.3.1 Hospital Acquired Infection Treatment Industry Trends
2.3.2 Hospital Acquired Infection Treatment Market Drivers
2.3.3 Hospital Acquired Infection Treatment Market Challenges
2.3.4 Hospital Acquired Infection Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital Acquired Infection Treatment Players by Revenue
3.1.1 Global Top Hospital Acquired Infection Treatment Players by Revenue (2019-2024)
3.1.2 Global Hospital Acquired Infection Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Hospital Acquired Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital Acquired Infection Treatment Revenue
3.4 Global Hospital Acquired Infection Treatment Market Concentration Ratio
3.4.1 Global Hospital Acquired Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Acquired Infection Treatment Revenue in 2023
3.5 Hospital Acquired Infection Treatment Key Players Head office and Area Served
3.6 Key Players Hospital Acquired Infection Treatment Product Solution and Service
3.7 Date of Enter into Hospital Acquired Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital Acquired Infection Treatment Breakdown Data by Type
4.1 Global Hospital Acquired Infection Treatment Historic Market Size by Type (2019-2024)
4.2 Global Hospital Acquired Infection Treatment Forecasted Market Size by Type (2025-2030)
5 Hospital Acquired Infection Treatment Breakdown Data by Application
5.1 Global Hospital Acquired Infection Treatment Historic Market Size by Application (2019-2024)
5.2 Global Hospital Acquired Infection Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hospital Acquired Infection Treatment Market Size (2019-2030)
6.2 North America Hospital Acquired Infection Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hospital Acquired Infection Treatment Market Size by Country (2019-2024)
6.4 North America Hospital Acquired Infection Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hospital Acquired Infection Treatment Market Size (2019-2030)
7.2 Europe Hospital Acquired Infection Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hospital Acquired Infection Treatment Market Size by Country (2019-2024)
7.4 Europe Hospital Acquired Infection Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital Acquired Infection Treatment Market Size (2019-2030)
8.2 Asia-Pacific Hospital Acquired Infection Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hospital Acquired Infection Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Hospital Acquired Infection Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hospital Acquired Infection Treatment Market Size (2019-2030)
9.2 Latin America Hospital Acquired Infection Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hospital Acquired Infection Treatment Market Size by Country (2019-2024)
9.4 Latin America Hospital Acquired Infection Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital Acquired Infection Treatment Market Size (2019-2030)
10.2 Middle East & Africa Hospital Acquired Infection Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hospital Acquired Infection Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Hospital Acquired Infection Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Hospital Acquired Infection Treatment Introduction
11.1.4 Abbott Revenue in Hospital Acquired Infection Treatment Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Hospital Acquired Infection Treatment Introduction
11.2.4 Pfizer Revenue in Hospital Acquired Infection Treatment Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Hospital Acquired Infection Treatment Introduction
11.3.4 Bayer Revenue in Hospital Acquired Infection Treatment Business (2019-2024)
11.3.5 Bayer Recent Development
11.4 Cepheid
11.4.1 Cepheid Company Detail
11.4.2 Cepheid Business Overview
11.4.3 Cepheid Hospital Acquired Infection Treatment Introduction
11.4.4 Cepheid Revenue in Hospital Acquired Infection Treatment Business (2019-2024)
11.4.5 Cepheid Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Detail
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Hospital Acquired Infection Treatment Introduction
11.5.4 AstraZeneca Revenue in Hospital Acquired Infection Treatment Business (2019-2024)
11.5.5 AstraZeneca Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Hospital Acquired Infection Treatment Introduction
11.6.4 Roche Revenue in Hospital Acquired Infection Treatment Business (2019-2024)
11.6.5 Roche Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Hospital Acquired Infection Treatment Introduction
11.7.4 Johnson & Johnson Revenue in Hospital Acquired Infection Treatment Business (2019-2024)
11.7.5 Johnson & Johnson Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Hospital Acquired Infection Treatment Introduction
11.8.4 Merck Revenue in Hospital Acquired Infection Treatment Business (2019-2024)
11.8.5 Merck Recent Development
11.9 Cipla
11.9.1 Cipla Company Detail
11.9.2 Cipla Business Overview
11.9.3 Cipla Hospital Acquired Infection Treatment Introduction
11.9.4 Cipla Revenue in Hospital Acquired Infection Treatment Business (2019-2024)
11.9.5 Cipla Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Detail
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Hospital Acquired Infection Treatment Introduction
11.10.4 GlaxoSmithKline Revenue in Hospital Acquired Infection Treatment Business (2019-2024)
11.10.5 GlaxoSmithKline Recent Development
11.11 Aridis Pharmaceuticals
11.11.1 Aridis Pharmaceuticals Company Detail
11.11.2 Aridis Pharmaceuticals Business Overview
11.11.3 Aridis Pharmaceuticals Hospital Acquired Infection Treatment Introduction
11.11.4 Aridis Pharmaceuticals Revenue in Hospital Acquired Infection Treatment Business (2019-2024)
11.11.5 Aridis Pharmaceuticals Recent Development
11.12 Astellas Pharma
11.12.1 Astellas Pharma Company Detail
11.12.2 Astellas Pharma Business Overview
11.12.3 Astellas Pharma Hospital Acquired Infection Treatment Introduction
11.12.4 Astellas Pharma Revenue in Hospital Acquired Infection Treatment Business (2019-2024)
11.12.5 Astellas Pharma Recent Development
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Company Detail
11.13.2 Daiichi Sankyo Business Overview
11.13.3 Daiichi Sankyo Hospital Acquired Infection Treatment Introduction
11.13.4 Daiichi Sankyo Revenue in Hospital Acquired Infection Treatment Business (2019-2024)
11.13.5 Daiichi Sankyo Recent Development
11.14 Bristol-Myers Squibb
11.14.1 Bristol-Myers Squibb Company Detail
11.14.2 Bristol-Myers Squibb Business Overview
11.14.3 Bristol-Myers Squibb Hospital Acquired Infection Treatment Introduction
11.14.4 Bristol-Myers Squibb Revenue in Hospital Acquired Infection Treatment Business (2019-2024)
11.14.5 Bristol-Myers Squibb Recent Development
11.15 Eli Lilly
11.15.1 Eli Lilly Company Detail
11.15.2 Eli Lilly Business Overview
11.15.3 Eli Lilly Hospital Acquired Infection Treatment Introduction
11.15.4 Eli Lilly Revenue in Hospital Acquired Infection Treatment Business (2019-2024)
11.15.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock